Erdafitinib is a potent, small-molecule kinase inhibitor that targets fibroblast growth factor receptors (FGFR) to treat specific types of cancer by blocking tyrosine kinase activity and inhibiting tumor… Read more







Erdafitinib is a potent, small-molecule kinase inhibitor that targets fibroblast growth factor receptors (FGFR) to treat specific types of cancer by blocking tyrosine kinase activity and inhibiting tumor cell proliferation and angiogenesis. To support the rigorous analytical demands of pharmaceutical development, this collection provides high-quality reference standards essential for comprehensive quality control and method validation. Laboratories utilize these materials, including impurities and degradation products such as nitroso derivatives, to ensure accurate impurity profiling and to maintain regulatory compliance throughout the manufacturing process. Additionally, the availability of stable isotope labelled compounds facilitates precise quantitative analysis, particularly in complex biological matrices or during pharmacokinetic studies where internal standards are required. These diverse analytical tools allow researchers to confidently monitor drug purity, identify potential process-related contaminants, and ensure the safety and efficacy of the final pharmaceutical product.